







IMPORTANT!
THE PRICE OF THE TEST INCLUDES A DNA SAMPLE COLLECTION KIT.
The Apixmed Prism Liver, Gallbladder and Pancreas genetic test covers 38 markers across seven areas of hepatobiliary and pancreatic function, including 29 complex markers and 9 individual genetic variants in 8 genes.
A DNA kit for collecting your saliva sample yourself is already included in the price of the test.
Genotyping of the sample in an accredited laboratory.
A report explaining 38 markers and genetic variants in plain language, with an interpretation of the results:
29 polygenic (complex) traits with an explanation of your individual result and what it means;
9 individual genetic variants with an explanation of their possible biological significance.
Context for every marker: genetics is not considered in isolation from lifestyle, age, environment and other factors.
Personalized recommendations on nutrition, physical activity, sleep, lifestyle and preventive approaches.
The option of a consultation with an Apixmed Prism specialist based on your report results.
Pointers to potentially relevant laboratory or clinical parameters that you can discuss with your doctor.
Data protection in line with ISO 27001, GDPR and HIPAA standards.
The Liver, Gallbladder and Pancreas genetic test covers seven areas, within which it analyzes 29 complex markers and 9 individual genetic variants in 8 genes: from liver enzymes to liver fat accumulation, gallbladder status and pancreatic function. It assesses how your genetic profile and individual genetic variants are associated with a relatively higher or lower predisposition for each marker compared with a reference population. The test does not measure any marker directly — instead it examines the stable genetic context that complements blood chemistry testing and ultrasound rather than replacing them.
DNA sample collection is done using saliva. You receive the kit by post and collect your own DNA sample into a special tube — it takes just a few minutes and requires no preparation. The sample is then sent for analysis to an accredited laboratory, and you receive your result in digital format.
29 markers across seven areas. Assessed using polygenic risk scores: tens and hundreds of variants together shape the contribution to a predisposition, and no single one of them determines the picture on its own.
Liver enzymes and plasma proteins: alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), bilirubin, albumin, liver fat fraction, liver iron content
Metabolic liver disease: metabolic dysfunction-associated steatotic liver disease (MASLD, also known as fatty liver disease), metabolic dysfunction-associated steatohepatitis (MASH), alcohol-related liver disease
Inflammatory and infectious liver disease: hepatitis B, hepatitis C
Fibrosis, cirrhosis and cholestasis: liver fibrosis, liver cirrhosis, reduced bile flow, biliary cholangitis
Gallbladder and bile duct conditions: gallstone disease, cholecystitis, sclerosing cholangitis
Hepatobiliary cancers: liver cancer, bile duct cancer, gallbladder cancer
Pancreatic function and disease: amylase, lipase, pancreatitis, type 1 diabetes, type 2 diabetes, pancreatic cancer
9 genetic variants in 8 genes. A mechanistic link to the trait is described for each, so they are interpreted individually and are not included in the complex markers.
HFE: the C282Y and H63D variants, most often linked to hereditary hemochromatosis (iron overload in the liver)
GSTP1: associated with detoxification processes in the liver
NQO1: associated with antioxidant defense in the liver
MBOAT7, PNPLA3, TM6SF2 and GCKR: associated with liver fat accumulation and MASLD
ABCG8: associated with gallstone disease
Family history of MASLD or hemochromatosis: specific genetic context for a conversation with a gastroenterologist.
Metabolic risk factors (weight, glucose, triglycerides): additional context on liver workload.
Interest in long-term prevention: specific topics for routine check-ups instead of guesswork.
When choosing supplements: a reason to discuss whether they are appropriate with your doctor, not grounds to change anything on your own.
The Liver, Gallbladder and Pancreas test is not a diagnosis and does not replace consultation with a doctor.
The results assess probability rather than establishing a predetermined outcome. They are not a diagnosis, do not confirm a disease and do not determine treatment. The test does not replace liver blood chemistry, ultrasound or other investigations. Clinical decisions are made by a specialist, taking into account your history, symptoms, diet, age, medication and laboratory data.